The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

Postepy w Chirurgii Glowy i Szyi - Advances in Head and Neck Surgery is a premier journal dedicated to advancing the field of head and neck surgery, published by TERMEDIA PUBLISHING HOUSE LTD. This journal serves as a vital resource for researchers, clinicians, and students, bringing together innovative research, clinical strategies, and reviews on both surgical techniques and emerging technologies in the realm of otolaryngology. As a publication aimed at enhancing surgical practices, it addresses critical issues and advancements that contribute to patient care, rehabilitation, and surgical outcomes. Although currently there is no impact factor listed, the journal's relevance is underscored by its commitment to publishing high-quality, peer-reviewed articles. With a focus on both established and newer practitioners in the field, Postepy w Chirurgii Glowy i Szyi offers an essential platform for dialogue and discovery in head and neck surgery, reinforcing its importance in shaping the future of this specialized area.

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

ACTA OTO-LARYNGOLOGICA is a prestigious academic journal focusing on the field of otorhinolaryngology, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0001-6489 and E-ISSN 1651-2251, this journal has been a cornerstone in the dissemination of research in otolaryngology since its inception in 1918. It maintains a solid impact factor in the scholarly community, categorized in 2023 as Q3 in Medicine (miscellaneous) and Q2 specifically in Otorhinolaryngology, indicating its significance and quality of published work. Researchers and practitioners benefit from comprehensive articles that offer insights and advancements in clinical practices, surgical techniques, and emerging trends in the field. Though it follows a subscription model, ACTA OTO-LARYNGOLOGICA strives to remain accessible for professionals seeking the latest research findings that can enhance patient care and clinical decision-making. By fostering a platform for quality scholarship, the journal plays an essential role in advancing the science and practice of otorhinolaryngology, making it invaluable for researchers, medical professionals, and students alike.

ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

OTO Open is a distinguished peer-reviewed journal published by WILEY, dedicated to the field of Otorhinolaryngology and its associated surgical disciplines. Since its inception in 2017, it has established itself as an Open Access platform, ensuring that groundbreaking research is accessible to a global audience. With a notable impact factor reflecting its relevance, OTO Open ranks in the top quartiles for both Otorhinolaryngology (Q1) and Surgery (Q2) as of 2023, showcasing its influential contributions to the medical community. The journal is indexed in Scopus, holding a significant position in both the Medicine & Surgery and Medicine & Otorhinolaryngology categories. Spanning years from 2017 to 2024, OTO Open serves as a critical resource for researchers, professionals, and students alike, promoting innovative insights and advancements in the field. The journal is based in the United States, at 111 River St, Hoboken, NJ, and looks forward to continuing its mission of advancing knowledge and research in otorhinolaryngology.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

Journal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.

Journal of Laryngology and Otology, published by Cambridge University Press, is a prestigious peer-reviewed journal dedicated to the fields of laryngology and otology. With its rich history dating back to 1891, the journal provides a platform for cutting-edge research, review articles, and clinical studies that advance the understanding and treatment of disorders related to the ear, nose, and throat. As evidenced by its ranking in the Q2 category for both Medicine (miscellaneous) and Otorhinolaryngology, the journal is recognized for its significant contributions to medical literature, holding its place at Rank #45 among 123 in the Scopus database for this specialty. Although it does not offer open access, it is widely accessible to professionals and academics in the field, and remains an invaluable resource for those seeking to stay updated with the latest advancements in laryngology and otology. The ISSN for the journal is 0022-2151 and the E-ISSN is 1748-5460, ensuring its broad reach and appeal within the global scientific community.

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.